Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
38198
CAS Number:
257933-82-7
Pélitinib
Purity:
≥ 97 % (HPLC)
Synonym(s):
EKB 569, (2 E - N -[4-[(3-chloro-4-fluorophényl)amino]-3-cyano-7-éthoxy-6-quinolinyl]-4-diméthylamino-2-buténamide
Hazmat
Documents
$261.99 /25 mg
Taille
Request Bulk Quote
Informations sur le produit
Numéro CAS 
257933-82-7
Formule moléculaire
C24H23ClFN5O2
Poids moléculaire 
0
Point de fusion 
197 - 199 °C
Informations générales
Numéro CAS 
257933-82-7
Formule moléculaire
C24H23ClFN5O2
Poids moléculaire 
0
Point de fusion 
197 - 199 °C
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Pelitinib is widely utilized in research focused on:

  • Cancer Treatment: Pelitinib is primarily studied for its potential in treating various types of cancer, particularly non-small cell lung cancer (NSCLC). Its targeted action on specific cancer cell pathways makes it a promising candidate for personalized medicine.
  • Drug Development: Researchers are exploring Pelitinib as a lead compound for developing new anti-cancer drugs. Its unique structure allows for modifications that can enhance efficacy and reduce side effects compared to traditional chemotherapy agents.
  • Combination Therapies: Pelitinib is being investigated in combination with other therapies to improve treatment outcomes. This approach can help overcome resistance mechanisms that often limit the effectiveness of single-agent treatments.
  • Biomarker Research: The use of Pelitinib in clinical studies is aiding the identification of biomarkers that predict patient responses to treatment, which is crucial for optimizing therapy and improving patient outcomes.
  • Pharmacokinetic Studies: Pelitinib's pharmacokinetic profile is being analyzed to understand its absorption, distribution, metabolism, and excretion in the body, providing valuable information for dosage optimization and safety assessments.

Citations